The Vulnerability to a COVID-19 Outbreak in Malaysia
Panel Analysis During the Endemic Phase
DOI:
https://doi.org/10.32890/jgd2022.18.1.1Kata kunci:
COVID-19, Vulnerability, Vaccination Program, MalaysiaAbstrak
Reaching the endemic phase of COVID-19 starting April 1, 2022, Malaysia had move forward for their normal norm. No more home
isolation and even mask mandate is unnecessary. With the vaccination status (completed 2nd dose), people can freely access the premises. However, Ministry of Health did not take COVID-19 for granted. The ministry keeps updating daily new cases to remind public the urgency to prevent the COVID-19 outbreak. This study describes the vulnerability of the COVID-19 outbreak in Malaysia by assessing relationship between the vaccination status to the number of COVID-19 cases. The data is taken from the ministry and panel data is taken to test within the period of endemic phase (April 2022- June 2022). The key findings will provide the relationship between the access variables and further research should be conducted to provide relevancy of this matter especially during endemic phase.
Rujukan
Chandran Shankar, Arjuna. (2021, June 22). Malaysia has received 8.59 mil vaccine doses from Pfizer, Sinovac, AstraZeneca so far — MOH. The Edge Markets. Retrieved September 27, 2022, from https://www.theedgemarkets.com/article/malaysia-has-received-859-million-vaccine-doses-pfizer-sinovac-astrazeneca-thus-far-%E2%80%94-moh Coronavirus (COVID-19) vaccinations. (n.d.). Our World in Data. Retrieved September 27, 2022, from https://ourworldindata. org/COVID-vaccinations?country=OWID_WRL
COVIDNOW. (2022, 17). Vaccinations in Malaysia. Retrieved September 27, 2022, from https://COVIDnow.moh.gov.my/ vaccinations/
Free Malaysia Today. (2021, February 16). Health ministry lists 605 COVID-19 vaccination centres. Retrieved September 27, 2022, from https://www.freemalaysiatoday.com/category/ nation/2021/02/16/health-ministry-lists-605-COVID-19-vaccination-centres/
Ministry of Health Malaysia. (2022, May 14). COVID terkini. COVID-19 MALAYSIA. Retrieved September 26, 2022, from https://COVID-19.moh.gov.my/info-terkini/COVID-terkini
Ng, J. W., Chong, E. T., Tan, Y. A., Lee, H. G., Chan, L. L., Lee, Q. Z., Saw, Y. T., Wong, Y., Zakaria, A. A., Amin, Z. B., & Lee, P. (2022). Prevalence of coronavirus disease 2019 (COVID-19) in different clinical stages before the national COVID-19 vaccination programme in Malaysia: A systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 19(4), 2216. https://doi.org/10.3390/ijerph19042216
Sim, B. L., Chidambaram, S. K., Wong, X. C., Pathmanathan, M. D., Peariasamy, K. M., Hor, C. P., Chua, H. J., & Goh, P. P. (2020). Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study. The Lancet Regional Health - Western Pacific, 4, 100055. https://doi.org/10.1016/j.lanwpc.2020.100055
Wong, W. K., Juwono, F. H., & Chua, T. H. (2021). SIR Simulation of COVID-19 Pandemic in Malaysia: Will the Vaccination Program be effective? arXiv. https://arxiv.org/abs/2101.07494
Muat turun
Diterbitkan
Terbitan
Bahagian
Cara Memetik
##plugins.generic.citations.panel.title##
##plugins.generic.citations.panel.harvested## 2026-09-08##plugins.generic.citations.panel.body##
- OpenAlex 0 ##plugins.generic.citations.panel.view##
- OpenCitations 0 ##plugins.generic.citations.panel.view##
- Crossref 0 ##plugins.generic.citations.panel.view##
- Google Scholar ##plugins.generic.citations.panel.noApi## ##plugins.generic.citations.panel.search##
- Dimensions ##plugins.generic.citations.panel.noApi## ##plugins.generic.citations.panel.search##











